Profound Medical (PROF) Stock Statistics & Valuation Metrics
Total Valuation
Profound Medical has a market cap or net worth of $239.99M. The enterprise value is $298.96M.
- Market Cap
- $239.99M
- Enterprise Value
- $298.96M
Share Statistics
Profound Medical has 36,532,593 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 36,532,593
- Owned by Insiders
- 3.08%
- Owned by Institutions
- 4.77%
Financial Efficiency
Profound Medical’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -31.10%.
- Return on Equity (ROE)
- -0.65
- Return on Assets (ROA)
- -0.31
- Return on Invested Capital (ROIC)
- -31.10%
- Return on Capital Employed (ROCE)
- -0.31
- Revenue Per Employee
- 101.11K
- Profits Per Employee
- -267.38K
- Employee Count
- 162
- Asset Turnover
- 0.12
- Inventory Turnover
- 0.58
Valuation Ratios
The current PE Ratio of Profound Medical is -6.79. Profound Medical’s PEG ratio is -0.17.
- PE Ratio
- -6.79
- PS Ratio
- 12.68
- PB Ratio
- 4.81
- Price to FCF
- -6.72
- Price to Operating Cash Flow
- -6.72
- PEG Ratio
- -0.17
Income Statement
In the last 12 months, Profound Medical had revenue of 16.38M and earned -43.32M in profits. Earnings per share was -1.43.
- Revenue
- 16.38M
- Gross Profit
- 11.59M
- Operating Income
- -41.98M
- Pretax Income
- -43.06M
- Net Income
- -43.32M
- EBITDA
- -41.41M
- Earnings Per Share (EPS)
- -1.43
Cash Flow
In the last 12 months, operating cash flow was -35.61M and capital expenditures -179,087, giving a free cash flow of -35.79M billion.
- Operating Cash Flow
- -35.61M
- Free Cash Flow
- -35.79M
- Free Cash Flow per Share
- -0.98
Dividends & Yields
Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -14.91%
- Earnings Yield
- -13.58%
Stock Price Statistics
- Beta
- 0.95
- 52-Week Price Change
- 7.35%
- 50-Day Moving Average
- 6.23
- 200-Day Moving Average
- 6.65
- Relative Strength Index (RSI)
- 58.72
- Average Volume (3m)
- 192.74K
Important Dates
Profound Medical upcoming earnings date is Nov 05, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Profound Medical as a current ratio of 12.52, with Debt / Equity ratio of 7.09%
- Current Ratio
- 12.52
- Quick Ratio
- 11.17
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 1.33
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Profound Medical has paid 256.41K in taxes.
- Income Tax
- 256.41K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Profound Medical EV to EBITDA ratio is -6.26, with an EV/FCF ratio of -5.84.
- EV to Sales
- 11.03
- EV to EBITDA
- -6.26
- EV to Free Cash Flow
- -5.84
- EV to Operating Cash Flow
- -5.87
Balance Sheet
Profound Medical has $38.21M in cash and marketable securities with $7.37M in debt, giving a net cash position of $30.84M billion.
- Cash & Marketable Securities
- $38.21M
- Total Debt
- $7.37M
- Net Cash
- $30.84M
- Net Cash Per Share
- $0.84
- Tangible Book Value Per Share
- $1.36
Margins
Gross margin is 71.73%, with operating margin of -184.35%, and net profit margin of -170.92%.
- Gross Margin
- 71.73%
- Operating Margin
- -184.35%
- Pretax Margin
- -169.74%
- Net Profit Margin
- -170.92%
- EBITDA Margin
- -176.27%
- EBIT Margin
- -178.84%
Analyst Forecast
The average price target for Profound Medical is $11.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $11.33
- Price Target Upside
- 72.50% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 61.19%
- EPS Growth Forecast
- 32.01%
Scores
- Smart Score
- 7
- AI Score
- ―